{"id": "1359284258901291011", "creation": 1612913596.0, "user_id": "86970530", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 6, "reply_count": 1, "like_count": 15, "quote_count": 0}}, "text": "Nice #SciComm on persistent #SARSCoV2 infxn. There are both indiv patient &amp; #publichealth reasons to prioritize ppl w/ compromised immune systems for #COVID19 #vaccine. A huge shame ppl w/ #cancer have not been studied in these COVID-19 #clinicaltrials.\n  https://t.co/vNEk6O5ZiD", "first_save": 1634559108.199414, "hashtags": ["#SCICOMM", "#SARSCOV2", "#PUBLICHEALTH", "#COVID19", "#VACCINE", "#CANCER", "#CLINICALTRIALS"]}